2017 Lupus Insight Prize Presented to Dr. Virginia Pascual
En Español
Email Sign Up
Give
Search
En Español
Sign Up for Updates
Who We Are
About Us
Our Impact
Strategic Plan Highlights
Our History
Our Commitment to Community
Financials
Careers
Leadership and Partners
Board of Directors
Research Committee of the Board
Scientific Advisory Board
Leadership and Partners
Executive Staff
Young Leaders Board
About Lupus
What is Lupus?
Symptoms
How is Lupus Diagnosed?
Treatment
Educational Resources
Our Research
About Our Research
Research Roadmap
Research We Fund
Get Involved in Research
Lupus Nexus
Participate in the Lupus Landmark Study
Lupus Therapeutics, LLC
For Researchers
Funding Opportunities
Funded Research
Research Partners
Scientific Resources
Research Contacts
LRA Reviewers 2023–2024
Press
Stories & News
Get Involved
Give
Online Donation
Other Ways to Give
Sponsorship Opportunities
Research
Find a Clinical Trial
Give to the Lupus Brain Bank
Participate in the Lupus Landmark Study
Events
Host an Event
Past Events
Walks
Marathons
Advocate
Take Action
Steps We’ve Taken
Advocacy News
ManyOne Can
Accelerating Lupus Research
Contact
Stories & News
News and Stories
2017 Lupus Insight Prize Presented to Dr. Virginia Pascual
Funds Major Study of Lupus Biomarkers to Predict Flares The 2017 Lupus Insight Prize was awarded on June 15th to...
News and Stories
The Who, What, Why’s of Lupus
Three lupus experts from Jacobi Medical Center answered these common questions at an educational seminar co-sponsored by the Lupus...
News and Stories
Advancing Lupus Care Through Research and Advocacy Conference
June 5, 2017
The First Collaborative Conference a Great Success The Lupus Research Alliance and Lupus Foundation New England recently co-hosted the Advancing...
News and Stories
Make Your Voice Heard on Lupus Drug Development
The national lupus patient advocacy community is excited to announce that people with lupus will have the chance to be...
News and Stories
Novel Research Grants Push Discoveries
10 New Grants, 10 New Insights The path to safe and effective treatments and ultimately a cure lies in bold,...
News and Stories
Aurinia Announces Voclosporin Meets 48-Week Remission Endpoints
Aurinia Pharmaceuticals Inc. (NASDAQ:AUPH / TSX:AUP) (“Aurinia” or the “Company”), a clinical stage biopharmaceutical company focused on the global...
Posts pagination
◀︎
1
…
51
52
53
Search Our Site
Search
X